Literature DB >> 19504618

Pityrosporum folliculitis in a Crohn's disease patient receiving infliximab.

Amana Nasir, Ehab El Bahesh, Chelsea Whitten, April Lawson, John N Udall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19504618     DOI: 10.1002/ibd.20928

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  6 in total

1.  Molecular Identification of Malassezia Species in Patients with Malassezia folliculitis in Sfax, Tunisia.

Authors:  F Cheikhrouhou; R Guidara; A Masmoudi; H Trabelsi; S Neji; H Sellami; F Makni; A Ayadi
Journal:  Mycopathologia       Date:  2017-01-20       Impact factor: 2.574

Review 2.  The Malassezia genus in skin and systemic diseases.

Authors:  Georgios Gaitanis; Prokopios Magiatis; Markus Hantschke; Ioannis D Bassukas; Aristea Velegraki
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

Review 3.  Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature.

Authors:  Sima S Toussi; Nancy Pan; Heather M Walters; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2013-07-29       Impact factor: 9.079

4.  Tumor necrosis factor-α inhibitor-induced follicular psoriasiform eruption.

Authors:  Tal Goldberger; Stephanie Benshushan; Zev Davidovics; Michael Wilschanski; Vered Molho-Pessach
Journal:  Pediatr Dermatol       Date:  2022-04-24       Impact factor: 1.997

Review 5.  Vaccines in Children with Inflammatory Bowel Disease: Brief Review.

Authors:  Susanna Esposito; Giulia Antoniol; Marialuisa Labate; Lucrezia Passadore; Patrizia Alvisi; Valeria Daccò; Chiara Ghizzi; Carla Colombo; Nicola Principi
Journal:  Vaccines (Basel)       Date:  2021-05-11

6.  The C-Type Lectin Mincle: Clues for a Role in Crohn's Disease Adjuvant Reaction.

Authors:  Anje A Te Velde
Journal:  Front Immunol       Date:  2017-10-23       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.